NCT01779609View on ClinicalTrials.gov

ET-blockade and Exercise-induced Vascular Adaptations in T2DM

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Bosentan

DRUG

Placebo

BEHAVIORAL

Exercise

Supervised exercise training program of 8 weeks, for 3x/week

Trial Locations (1)

6525 EX

Radboud University Nijmegen Medical Centre, Nijmegen

Sponsors

Collaborators (1)

Actelion
All Listed Sponsors
collaborator

Actelion

INDUSTRY

lead

Radboud University Medical Center

OTHER

NCT01779609 - ET-blockade and Exercise-induced Vascular Adaptations in T2DM | Biotech Hunter | Biotech Hunter